TCM Composition for Infectious Disease Recovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective traditional Chinese medicine compositions and preparations to prevent, treat, or alleviate sequelae or complications of infectious diseases, such as COVID-19 pneumonia, which cause damage to tissues, organs, or systems, and to promote function recovery.
Innovation Solution
A traditional Chinese medicine composition comprising Ginseng Radix et Rhizoma, Ophiopogonis Radix, Schisandrae Chinensis Fructus, Poria, Pinelliae Rhizoma Praeparatum Cum Alumine, Scrophulariae Radix, bran-fried Atractylodis Rhizoma, Citri Reticulatae Pericarpium, Glycyrrhizae Radix et Rhizoma, Bupleuri Radix, Cimicifugae Rhizoma, Coicis Semen, Scutellariae Radix, Verbenae Herba, Phragmitis Rhizoma, and Lophatheri Herba, which can be formulated into various dosage forms like powders, granules, or extracts, is used to address the sequelae and complications of infectious diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional Chinese medicine is used to treat infectious diseases, then the disease can be effectively prevented and treated, but the recovery phase is prolonged and physiological function recovery is delayed
Solution Approach 1:
The patent applies preliminary action by formulating a specialized TCM composition designed to be administered during the recovery phase after clinical cure. This composition proactively addresses physiological function recovery before complete recovery occurs, rather than waiting for natural recovery processes. The formulation includes herbs specifically selected to accelerate organ function restoration and reduce recovery time.
Solution Approach 2:
The patent changes the therapeutic parameters by shifting from disease-focused treatment to recovery-focused intervention. The composition modifies the physiological state parameters of the patient during recovery, targeting specific organ functions and systems to accelerate their restoration to normal levels, thereby reducing the overall recovery phase duration.
2Reliability
If conventional treatment is used to achieve clinical cure, then infectious disease symptoms are resolved, but sequelae and complications persist affecting quality of life
Solution Approach 1:
The patent extracts and specifically targets the residual pathological factors that cause sequelae and complications after clinical cure. The TCM composition is designed to remove these remaining harmful elements such as lingering heat, toxin residues, and functional imbalances that conventional treatment may not fully address, thereby eliminating the source of ongoing symptoms.
Solution Approach 2:
The patent introduces a specialized TCM composition as an intermediary therapeutic agent that bridges the gap between clinical cure and complete recovery. This composition mediates the transition by addressing intermediate pathological states and facilitating the elimination of sequelae, acting as a bridge between the acute treatment phase and full recovery.
3Adaptability or versatility
If TCM composition includes multiple herbal ingredients to address various sequelae, then comprehensive recovery is achieved, but formulation complexity increases
Solution Approach 1:
The patent merges multiple herbal ingredients into a single integrated TCM composition formulation. By combining herbs with complementary therapeutic actions into one coordinated formula, the patent achieves comprehensive coverage of various sequelae and complications while presenting a unified, manageable preparation that simplifies administration compared to multiple separate treatments.
Solution Approach 2:
The patent creates a universal TCM composition with multi-functional capabilities that can address various types of sequelae and complications from different infectious diseases. The formulation is designed to simultaneously target multiple organ systems and pathological mechanisms, providing broad-spectrum recovery support without requiring disease-specific customization.
Data Source
AI summary
A traditional Chinese medicine composition for infectious disease recovery, containing the Chinese medicinal herbs: 2-4 parts of ginseng, 4-8 parts of Ophiopogon japonicus, 2-4 parts of Schisandra chinensis berry, 6-10 parts of Wolfiporia extensa Ginns, 6-10 parts of rhizoma pinelliae, 4-8 parts of Scrophularia ningpoensis, 4-6 parts of stir-fried Atractylodes, 4-8 parts of mandarin orange peel, 2-4 parts of Glycyrrhiza uralensis, 4-8 parts of Bupleurum scorzonerifolium, 2-4 parts of Actaea cimicifuga, 8-12 parts of Coix lacryma-jobi, 8-12 parts of Scutellaria baicalensis, 8-12 parts of Verbena officinalis, 12-18 parts of rhizoma phragmitis, and 1-3 parts of Lophatherum gracile. The present traditional Chinese medicine composition can be used in medicines for the prevention, treatment, or alleviation of the sequelae or complications of infectious diseases or for the promotion of the functional recovery of damaged tissues, organs or systems caused by infectious diseases.